Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2021
July 31, 2020 at 12:00 am EDT
Share
Yuki Gosei Kogyo Co., Ltd. provided non-consolidated earnings guidance for the First Half and fiscal year ending March 31, 2021. For the first half, the company expects net sales of JPY 5,300 million, operating income of JPY 70 million, ordinary income of JPY 50 million and net income of JPY 40 million or net income per share of JPY 1.83 per share.
For the fiscal year, the company expects net sales of JPY 11,300 million, operating income of JPY 250 million, ordinary income of JPY 220 million and net income of JPY 160 million or net income per share of JPY 7.33 per share.
Yuki Gosei Kogyo Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of amino acids, chemicals and pharmaceuticals. The amino acids business is involved in the manufacture and sale of amino acids and vitamin ingredients. The chemical products business in involved in the manufacture and sale of the tire cord adhesive raw materials, agricultural chemical intermediates, silicon compounds and other products. The pharmaceuticals business is involved in the manufacture and sale of the pharmaceutical raw materials and intermediates. The commission of manufacture operation business is involved in the contract for manufacture operations through subsidiaries. The Company is also involved in the manufacture and sale of foods, food additives, feed additives, fragrances, and cosmetics, as well as the sale of the related raw materials and products.
YUKI GOSEI KOGYO CO., LTD. 